AC Immune

Clinical stage Swiss-based biopharmaceutical company focused on neurodegenerative diseases. Learn more

Launch date

2003

Employees

Market cap

Enterprise valuation

€103m (Public information from Sep 2024)

Company register number CH-270.4.013.417-2

Lausanne Canton of Vaud (HQ)

http://acimmune.com

https://twitter.com/ac_immune_sa https://www.linkedin.com/company/ac-immune

View job openings

Authorizing premium user...